Category Archives: People

Chemomab Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update

—New Clinical and Translational Data Presented at Major Medical Meetings Further Confirms the Disease-Modifying Potential of Nebokitug in Primary Sclerosing Cholangitis and Suggests Possible Additional Benefit in PSC Patients with Co-Existing IBD— —Company Continues to Advance Multiple Partnering Options for Nebokitug— TEL AVIV, Israel, May 14, 2026 (GLOBE NEWSWIRE) — Chemomab Therapeutics Ltd. (Nasdaq: CMMB), […]

COTY DEADLINE: ROSEN, A HIGHLY RECOGNIZED INVESTOR RIGHTS FIRM, Encourages Coty Inc. Investors to Secure Counsel Before Important May 22 Deadline in Securities Class Action – COTY

NEW YORK, May 13, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Coty Inc. (NYSE: COTY) between November 5, 2025 and February 4, 2026, inclusive (the “Class Period”), of the important May 22, 2026 lead plaintiff deadline. SO WHAT: If you purchased Coty […]

Lulus Reports First Quarter 2026 Results

Net Loss Improves by $3.9 Million in Q1’26 vs Q1’25 Underscoring Continued Operational and Financial Momentum Gross Margin increased 480 basis points in Q1’26 vs Q1’25 Reduced Total Debt by $1.1M and Net Debt by $5.8M During Q1’26 CHICO, Calif., May 13, 2026 (GLOBE NEWSWIRE) — Lulu’s Fashion Lounge Holdings, Inc. (“Lulus” or the “Company”) […]

Interactive Cosmetic Education Continues to Receive Enthusiastic Feedback

Over 80 dermatology residents gathered in Dallas, Texas, on April 17-19 for the 2026 ASDS Premier Annual Resident Cosmetic Symposium. Educational topics spanned a variety of cosmetic procedures, device overviews, live patient assessments, anatomy demonstrations, hands-on training and interactive discussions. Schaumburg, IL, May 13, 2026 (GLOBE NEWSWIRE) — The American Society for Dermatologic Surgery (ASDS) […]

Orivelle Fungus Pen Analyzed: All You Need To Know About Orivelle Nail Care Pen Device

New York City, NY, May 13, 2026 (GLOBE NEWSWIRE) — Orivelle Nail Care Pen, at a glance, is a plant-based, powerful pen that is currently being talked about in thousands of American homes. One of the most common and under-reported cosmetic issues impacting individuals in the US is nail fungus.  Creams that are applied to […]

iHerb Launches Quality Promise to Elevate Trust and Transparency Across Customer Experience

USA TODAY Names iHerb One of America’s Best Customer Service Companies for Second Consecutive Year IRVINE, Calif., May 13, 2026 (GLOBE NEWSWIRE) — iHerb, a leading global eCommerce retailer specializing in vitamins, minerals, supplements and other health and wellness products, today announced the rollout of its new iHerb Quality Promise, a comprehensive initiative designed to […]

Hard Chews Gummies Claims Evaluated: Investigating the Salt Tonic Trick Recipe for Men

Hard Chews Gummies Ingredients, Male Performance Support, L-Arginine, Tongkat Ali, Maca Root, 180-Day Guarantee, Pricing, and Subscribe and Save Researched Aurora, CO, May 13, 2026 (GLOBE NEWSWIRE) — These statements have not been evaluated by the Food and Drug Administration. Hard Chews Gummies are not intended to diagnose, treat, cure, or prevent any disease. Consult […]

Venus Concept Announces Senior Management Changes

TORONTO, May 13, 2026 (GLOBE NEWSWIRE) — Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced changes to its senior leadership team. Kirk Gunhus, Chief Revenue Officer, departed the Company as of May 8th, 2026, to pursue another professional opportunity. Mr. Gunhus joined Venus in 2023 and had […]

Management team’s 2025 market-based Options have vested

Share price increase from $6 to $30 triggers full vesting NEW HAVEN, Conn., May 13, 2026 (GLOBE NEWSWIRE) — Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces that 2025 employee stock options granted to certain members of Precipio’s management team vested last week because the Company’s Common Stock price increased by more than 400% since the […]

Aptose Reports First Quarter 2026 Results 

SAN DIEGO and TORONTO, May 13, 2026 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS and OTC: APTOF), a clinical-stage precision oncology company developing a tuspetinib (TUS)-based triple drug frontline therapy to treat patients with newly diagnosed acute myeloid leukemia (AML), today announced financial results for the first quarter ended March […]